Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
2(22%)
Results Posted
40%(2 trials)
Terminated
1(11%)

Phase Distribution

Ph early_phase_1
1
11%
Ph not_applicable
4
44%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Early Phase 1First-in-human
1(20.0%)
N/ANon-phased studies
4(80.0%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

2

trials recruiting

Total Trials

9

all time

Status Distribution
Active(2)
Completed(5)
Terminated(2)

Detailed Status

Completed5
Recruiting2
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
2
Success Rate
83.3%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (20.0%)
N/A4 (80.0%)

Trials by Status

recruiting222%
terminated111%
completed556%
withdrawn111%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DEVICE
Total Trials
9